UPLOAD Filing
KIORA PHARMACEUTICALS INC
Date: July 1, 2025 · CIK: 0001372514 · Accession: 0000000000-25-006943
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-36672
Letter
Re: Kiora Pharmaceuticals, Inc. Form 10-K for the fiscal year ended December 31, 2024 Filed March 25, 2025 File No. 001-36672 Dear Melissa Tosca:
July 1, 2025
Melissa Tosca Chief Financial Officer Kiora Pharmaceuticals, Inc. 332 Encinitas Blvd., Suite 102 Encinitas, CA 92024
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> July 1, 2025 Melissa Tosca Chief Financial Officer Kiora Pharmaceuticals, Inc. 332 Encinitas Blvd., Suite 102 Encinitas, CA 92024 Re: Kiora Pharmaceuticals, Inc. Form 10-K for the fiscal year ended December 31, 2024 Filed March 25, 2025 File No. 001-36672 Dear Melissa Tosca: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>